Toripalimab

Loqtorzi Concentrate for Solution for Infusion 240MG/6ML

240mg/6mL infusion, solution concentrateSingaporeAuthorisedAuthorised 26 Mar 2025

In other countries

The same active substances on other registers, the same brand first.

LoqtorziCanada · 40 MG / ML · Solution · Apotex INCSame brand
Loqtorzi 240 MG Concentrado Para Solucion Para PerfusionSpain · 240 mg · concentrado para solución para perfusión · Topalliance Biosciences Europe LimitedSame brand
LoqtorziEuropean Union · Topalliance Biosciences Europe LimitedSame brand
LoqtorziCroatiaSame brand
LoqtorziItaly · Concentrato per soluzione per infusione · Topalliance Biosciences Europe LimitedSame brand
LOQTORZI 240 mg concentraat voor oplossing voor infusieNetherlands · Concentraat voor oplossing voor infusie · Topalliance Biosciences Europe LimitedSame brand
LoqtorziUnited States · 240MG/6ML · injectable · Coherus Biosciences INC

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Toripalimab

Loqtorzi Concentrate for Solution for Infusion 240MG/6ML

240mg/6mL infusion, solution concentrateSingaporeAuthorisedAuthorised 26 Mar 2025

Ask Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

ZytorviBrazil · DR. Reddys Farmacêutica do Brasil Ltda

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Sciences Authority / data.gov.sg

Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence

Licence: Singapore Open Data Licence 1.0 · Added 8 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Toripalimab
Strength: 240mg/6mL
Dosage form: infusion, solution concentrate
Route: intravenous
Register: Singapore (HSA)
Status: Authorised
Status in the register: Registered
Authorised: 26 Mar 2025
Registration: SIN17212P
Marketing authorisation holder: Ta Biosciences Pte. LTD.
Manufacturer: Suzhou Union Biopharm Co., Ltd, CHINA
ATC code: L01FF13
Group: Antineoplastic and immunomodulating agents
Supply: Prescription Only